Featured Toolkit
Patient Safety Structural Measures (PSSM) Toolkit
As part of the FY2025 final rule, CMS is requiring hospitals to participate in the Hospital Inpatient Quality Reporti...
Learn MoreToolkits
Browse our extensive toolkit library for helpful tips, tools and resources designed to make your job easier!
Our toolkits are your one-stop-shop for information pertinent to improving processes, identifying best practices, reducing risks, obtaining education information, and much more.
Have an idea or a specific need for a toolkit you don’t see listed here? Please contact Vice President of Patient Safety & Risk Stacie Jenkins at staciejenkins@lhatrustfunds.com to share your suggestion.
Featured Toolkit
As part of the FY2025 final rule, CMS is requiring hospitals to participate in the Hospital Inpatient Quality Reporti...
Learn MoreSample patient consent to treatment with TM. This policy is most applicable to the physician office practice where the physician has been approved by LSBME to recommend TM. This language can be customized for your organization. The policy outlines side effects, risks and other important information regarding the medication.
This document, provided by the National Council of State Boards of Nursing, provides guidance to Boards of Nursing on assessment and decision making on issues related to marijuana. These guidelines address licensees who test positive for THC or metabolites, improper certifying of medical marijuana program qualifying conditions, and licensee’s administration of marijuana outside of a therapeutic marijuana program.
Medication errors can occur at any point in the medication delivery system. These guidelines provide the pharmacist with practical recommendations and best practices for preventing and mitigating patient harm from medication errors.
This policy statement, developed by the American Academy of Pediatrics, addresses medication errors in the pediatric population. The statement outlines safeguards that should be taken for pediatric patients, going above and beyond those for adults.
National Patient Safety Goals represent best practices with various processes. This R3 Report from The Joint Commission gives detailed information on the NPSG for anticoagulant therapy that includes the requirement, the rationale for why the requirement was developed, and the reference.
Although medication errors of any kind are dangerous, IV push medication administration can pose a significant risk to patients due to rapid bioavailability effects and a limited ability to reverse the medication’s impact. This is a comprehensive guide of safe practices compiled by the ISMP that can help reduce the risks to patients when administering medications via IV push.
403-408 out of 709
127-130 out of 130